In the study, researchers wanted to know what allowed cells to survive in one place instead of the other. To do this, they analyzed data from MetMap, a project at the Broad Institute, an independent ...

Median OS increased from 14.2 months with gemcitabine-paclitaxel chemotherapy to 16.2 months with the addition of TTFields. One-year survival also improved from 60.2% to 68.1% with the electric ...

Pancreatic cancer remains one of the most challenging malignancies, with a very poor prognosis. Current research is focused on elucidating the role of the tumour microenvironment and the ...

Scientists have discovered how pancreatic cancer cells thrive in the lungs or liver, environments that are as distinct to cells as the ocean and desert are to animals. The spread of cancer cells ...

Zai Lab Limited (NASDAQ:ZLAB) and NovoCure Limited (NASDAQ:NVCR) revealed additional data on Saturday from the Phase 3 PANOVA-3 trial of Tumor Treating Fields (TTFields) therapy for pancreatic cancer.

Pancreatic cancer is one of the most difficult cancers to treat — and the deadliest. Fewer than 10% of patients with advanced pancreatic cancer live beyond five years. A few factors account for this.

Actuate Therapeutics has set its sights on getting elraglusib approved for pancreatic cancer after the glycogen synthase kinase‐3 beta (GSK-3β) drug showed a three-month survival increase in a ...

TTField therapy with chemotherapy improved median overall and pain-free survival in pancreatic cancer, according to new data from the PANOVA-3 trial.

BAAR, Switzerland, May 31, 2025--Novocure (NASDAQ: NVCR) announced that results from the Phase 3 PANOVA-3 trial of Tumor Treating Fields (TTFields) therapy for pancreatic cancer will be presented ...

Kanisha Collins, 24, alleges her doctors didn't test a mass on her pancreas, telling her she was too young for pancreatic cancer; The mom of a toddler was in the midst of planning her wedding when ...

Tumor treating fields (TTFields) is a noninvasive therapy using low-intensity electric fields that disrupt cellular processes critical for cancer cell viability and tumor progression. 14 TTFields have ...

We know that everolimus can help people who have pancreatic neuroendocrine tumours that can’t be removed with surgery, or have spread to another part of the body. In this study, researchers want to.